FDA Import Refusal SCS-1640102-0/11/1 — Novartis Pharmaceuticals Canada Inc.

Novartis Pharmaceuticals Canada Inc. — FEI 3002260858

The FDA refused shipment SCS-1640102-0/11/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Sep 14, 2020. The refused product falls under Drugs and Biologics — ANTIBIOTIC N.E.C.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal details

Date
Sep 14, 2020
Country
Canada
Product Category
Drugs and Biologics
Product Code
56YBK99 ANTIBIOTIC N.E.C.
Charges
118,3280

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.